'Effectiveness of Penfluridol (long acting neuroleptic) as compared to second generation oral neuroleptics (olanzapine and risperidone) in psychotic disorder patients: an open label randomized controlled trial'
Suspended
- Conditions
- psychotic disordermedication compliancepenfluridololanzapinerisperidone
- Registration Number
- NL-OMON26965
- Lead Sponsor
- Erasmus University Medical Center, RotterdamPsychiatry Department
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- Not specified
- Target Recruitment
- 180
Inclusion Criteria
1. age 18-65 years
2. psychotic disorder, including schizophrenia, schizoaffective disorder, delusional disorder or psychosis not otherwise specified
Exclusion Criteria
1. judicial order stating that taking medication is obliged
2. patient did use penfluridol during the previous six months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method time to all-cause medication discontinuation
- Secondary Outcome Measures
Name Time Method - healthcare related costs<br /><br>- quality of life<br /><br>- reason for treatment discontinuation<br /><br>- efficacy<br /><br>- safety and tolerability<br /><br>- drug attitude<br /><br>- subjective well-being<br /><br>- insight<br />